Loading clinical trials...
Loading clinical trials...
Safety, Tolerability and Pharmacokinetic Studies of Single and Multiple Administrations of HRS-8829 in Healthy Subjects
Conditions
Interventions
HRS-8829;Placebo
HRS-8829;Placebo
+2 more
Locations
1
China
Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Start Date
July 1, 2025
Primary Completion Date
October 1, 2025
Completion Date
November 1, 2025
Last Updated
July 24, 2025
Lead Sponsor
Beijing Suncadia Pharmaceuticals Co., Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions